After several years of systematically applied structural prediction, rational design and protein engineering, Fate Therapeutics has generated several proprietary Wnt-protein drug candidates suitable for advancement toward clinical development and validated their therapeutic potential in various in vivo preclinical models.
http://www.biospace.com/news_story.aspx?StoryID=281230&full=1
http://www.biospace.com/news_story.aspx?StoryID=281230&full=1
No comments:
Post a Comment